tricalcium phosphate has been researched along with Inflammatory Bowel Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, A; Md Ramli, SH; Naharudin, I; Wong, TW | 1 |
| Coe, FL; O'Connor, RC; Parks, JH; Worcester, EM | 1 |
2 other study(ies) available for tricalcium phosphate and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Coatless alginate pellets as sustained-release drug carrier for inflammatory bowel disease treatment.
Topics: Alginates; Animals; Calcium Phosphates; Chemistry, Pharmaceutical; Colon; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Excipients; Female; Gastric Acid; Glucuronic Acid; Hexuronic Acids; Hydrophobic and Hydrophilic Interactions; Inflammatory Bowel Diseases; Rats; Rats, Sprague-Dawley; Solubility; Tablets | 2016 |
Urine stone risk factors in nephrolithiasis patients with and without bowel disease.
Topics: Calcium Oxalate; Calcium Phosphates; Citric Acid; Female; Humans; Hydrogen-Ion Concentration; Inflammatory Bowel Diseases; Kidney; Magnesium; Male; Nutritional Physiological Phenomena; Risk Factors; Sex Distribution; Uric Acid; Urinary Calculi; Urine | 2003 |